よむ、つかう、まなぶ。
会議資料 (129 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000198856_00046.html |
| 出典情報 | 医療上の必要性の高い未承認薬・適応外薬検討会議（第68回 5／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
要望番号；IV-177
performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun.
2016;37(1):57-65.
３１） Ergül N, Halac M, Cermik TF, Ozaras R, Sager S, Onsel C, et al. The Diagnostic Role of
FDG PET/CT in Patients with Fever of Unknown Origin. Mol Imaging Radionucl Ther.
2011;20(1):19-25.
３２） García-Vicente AM, Tello-Galán MJ, Amo-Salas M, Ros-Izquierdo J, Jiménez-Londoño GA,
Salas BLR, et al. Do clinical and laboratory variables have any impact on the diagnostic
performance of 18F-FDG PET/CT in patients with fever of unknown origin? Ann Nucl Med.
2018;32(2):123-31.
３３） Rosenbaum J, Basu S, Beckerman S, Werner T, Torigian DA, Alavi A. Evaluation of
diagnostic performance of 18F-FDG-PET compared to CT in detecting potential causes of fever
of unknown origin in an academic centre. Hell J Nucl Med. 2011;14(3):255-9.
３４） Seshadri N, Sonoda LI, Lever AM, Balan K. Superiority of 18F-FDG PET compared to
111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin. J Infect.
2012;65(1):71-9.
３５） Singh N, Kumar R, Malhotra A, Bhalla AS, Kumar U, Sood R. Diagnostic utility of
fluorodeoxyglucose positron emission tomography/computed tomography in pyrexia of unknown
origin. Indian J Nucl Med. 2015;30(3):204-12.
３６） Pedersen TI, Roed C, Knudsen LS, Loft A, Skinhoj P, Nielsen SD. Fever of unknown origin:
a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT. Scand
J Infect Dis. 2012;44(1):18-23.
３７） Nakayo EMB, Vicente AMG, Castrejón AMS, Narváez JAM, Rubio MPT, García VMP, et
al. Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of
(18)F-FDG PET-CT: a proposal of diagnostic algorithm. Rev Esp Med Nucl Imagen Mol.
2012;31(4):178-86.
３８） Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI
Guideline for 18F-FDG Use in Inflammation and Infection. J Nucl Med. 2013;54(4):647-58.
３９） Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the
diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med.
2011;25(5):355-64.
４０） Kubota K, Tanaka N, Miyata Y, Ohtsu H, Nakahara T, Sakamoto S, et al. Comparison of
18F‑FDG PET/CT and 67Ga‑SPECT for the diagnosis of fever of unknown origin: a multicenter
prospective study in Japan. Ann Nucl Med. 2021;35(1):31-46.
４１） Betrains A, Mulders-Manders CM, Aarntzen EH, Vanderschueren S, Rovers CP. Update on
imaging in fever and inflammation of unknown origin: focus on infectious disorders. Clin
Microbiol Infect. 2024;30(3):288-95.
４２） Haidar G, Singh N. Fever of Unknown Origin. N Engl J Med. 2022;386(5):463-77.
59
129/370
performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun.
2016;37(1):57-65.
３１） Ergül N, Halac M, Cermik TF, Ozaras R, Sager S, Onsel C, et al. The Diagnostic Role of
FDG PET/CT in Patients with Fever of Unknown Origin. Mol Imaging Radionucl Ther.
2011;20(1):19-25.
３２） García-Vicente AM, Tello-Galán MJ, Amo-Salas M, Ros-Izquierdo J, Jiménez-Londoño GA,
Salas BLR, et al. Do clinical and laboratory variables have any impact on the diagnostic
performance of 18F-FDG PET/CT in patients with fever of unknown origin? Ann Nucl Med.
2018;32(2):123-31.
３３） Rosenbaum J, Basu S, Beckerman S, Werner T, Torigian DA, Alavi A. Evaluation of
diagnostic performance of 18F-FDG-PET compared to CT in detecting potential causes of fever
of unknown origin in an academic centre. Hell J Nucl Med. 2011;14(3):255-9.
３４） Seshadri N, Sonoda LI, Lever AM, Balan K. Superiority of 18F-FDG PET compared to
111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin. J Infect.
2012;65(1):71-9.
３５） Singh N, Kumar R, Malhotra A, Bhalla AS, Kumar U, Sood R. Diagnostic utility of
fluorodeoxyglucose positron emission tomography/computed tomography in pyrexia of unknown
origin. Indian J Nucl Med. 2015;30(3):204-12.
３６） Pedersen TI, Roed C, Knudsen LS, Loft A, Skinhoj P, Nielsen SD. Fever of unknown origin:
a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT. Scand
J Infect Dis. 2012;44(1):18-23.
３７） Nakayo EMB, Vicente AMG, Castrejón AMS, Narváez JAM, Rubio MPT, García VMP, et
al. Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of
(18)F-FDG PET-CT: a proposal of diagnostic algorithm. Rev Esp Med Nucl Imagen Mol.
2012;31(4):178-86.
３８） Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI
Guideline for 18F-FDG Use in Inflammation and Infection. J Nucl Med. 2013;54(4):647-58.
３９） Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the
diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med.
2011;25(5):355-64.
４０） Kubota K, Tanaka N, Miyata Y, Ohtsu H, Nakahara T, Sakamoto S, et al. Comparison of
18F‑FDG PET/CT and 67Ga‑SPECT for the diagnosis of fever of unknown origin: a multicenter
prospective study in Japan. Ann Nucl Med. 2021;35(1):31-46.
４１） Betrains A, Mulders-Manders CM, Aarntzen EH, Vanderschueren S, Rovers CP. Update on
imaging in fever and inflammation of unknown origin: focus on infectious disorders. Clin
Microbiol Infect. 2024;30(3):288-95.
４２） Haidar G, Singh N. Fever of Unknown Origin. N Engl J Med. 2022;386(5):463-77.
59
129/370